The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
Open Access
- 11 December 2013
- journal article
- research article
- Published by Taylor & Francis Ltd in Hypertension in Pregnancy
- Vol. 33 (1), 81-92
- https://doi.org/10.3109/10641955.2013.837175
Abstract
Objective: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. Methods: Maternal circulating angiogenic factors (sFlt1 and PlGF) measured on automated platform were studied at four time points during pregnancy in women with diabetes (N = 159) and reported as multiples of the median (MOM) of sFlt1/PlGF ratio (median, 25th–75th percentile) noted in non-diabetic non-hypertensive control pregnant population (N = 139). Diagnosis of PE or GHTN was determined by review of de-identified clinical data. Results: PE developed in 12% (N = 19) and GHTN developed in 23% (N = 37) of the women with diabetes. Among diabetic women without PE or GHTN, median sFlt1/PlGF levels at 35–40 weeks was threefold higher than in non-diabetic controls [MOM 3.21(1.19–7.24), p = 0.0001]. Diabetic women who subsequently developed PE had even greater alterations in sFlt1/PlGF ratio during the third trimester [MOM for PE at 27–34 weeks 15.18 (2.37–26.86), at 35–40 weeks 8.61(1.20–18.27), p ≤ 0.01 for both windows compared to non-diabetic controls]. Women with diabetes who subsequently developed GHTN also had significant alterations in angiogenic factors during third trimester; however, these findings were less striking. Among women with diabetes, glycosylated hemoglobin (HbA1c) during the first trimester was higher in subjects who subsequently developed PE (7.7 vs 6.7%, p = 0.0001 for diabetic PE vs diabetic non-PE). Conclusions: Women with diabetes had a markedly altered anti-angiogenic state late in pregnancy that was further exacerbated in subjects who developed PE. Altered angiogenic factors may be one mechanism for the increased risk of PE in this population. Increased HbA1c in the first trimester of pregnancies in women with diabetes was strongly associated with subsequent PE.Keywords
This publication has 34 references indexed in Scilit:
- Microalbuminuria, Preeclampsia, and Preterm Delivery in Pregnant Women With Type 1 DiabetesDiabetes Care, 2009
- Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancyDiabetic Medicine, 2007
- Latest Advances in Understanding PreeclampsiaScience, 2005
- Pregnancy Outcome in Type 1 Diabetic Women With MicroalbuminuriaDiabetes Care, 2001
- Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with Type I diabetes mellitusDiabetologia, 2000
- Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitusThe Journal of Maternal-Fetal Medicine, 2000
- Epidemiology of pregnancy‐induced hypertension and preeclampsia in Type 1 (insulin‐dependent) diabetic pregnancies in SwedenActa Obstetricia et Gynecologica Scandinavica, 1998
- Early-pregnancy proteinuria in diabetes related to preeclampsia.1993
- Preeclampsia in diabetic pregnanciesAmerican Journal of Obstetrics and Gynecology, 1990
- Diabetic retinopathy in pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1984